Contact Us

Contact Us

Please contact us below with any questions

info@quadratech.co.uk

+44 (0)33 3321 2371

Side Contact
quadratech Logo
{{ toggleHam ? 'CLOSE' : 'MENU' }}
Next Day & International Delivery
Competitive Pricing
Over 30 Years Experience
Based In The UK

Human ACE2 (19-740) Recombinant Protein, Fc-Tag (CHO) (20µg) (Special Terms Apply*)

X

We're always working hard to give our customers as much information on products and the best price possible. If you need any assistance or would like a quote please contact us and we will be happy to help

Human ACE2 (19-740) Recombinant Protein, Fc-Tag (CHO) (20µg) (Special Terms Apply*) (QTXAG-637-20) is recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (19-740) binds to the SARS Coronavirus 2 (COV-2) receptor binding domain (RBD). It is expressed in CHO cells and purified to greater than 95% purity. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.

Product Brand:
Product Code: QTXAG-637-20
Description

Recombinant human angiotensin-converting enzyme 2 (ACE2) extracellular domain (19-740) was expressed in CHO cells using a C-terminal Fc-tag and binds to the SARS Coronavirus 2 (COVID-19) receptor binding domain (RBD).

*Special Terms: Please see product specification details below and our Ordering page for details.

Product Specification
Specification Type
Specification Value
Product Range
Product Code
QTXAG-637-20
Product Name
Human ACE2 (19-740) Recombinant Protein, Fc-Tag (CHO) (20µg) (Special Terms Apply*)
Product Category
Product Brand
Product Analyte or Application
Product Size
1 x 20 µg
Product Special Terms
Q-TOX Term 1: Shipped Frozen on Dry Ice. Additional Shipping Charge for Dry Ice & Freight Fee Applies
Q-TOX Term 2: Minimum Order Volume of 1000µg on Orders Requiring Dry Ice Shipment
Product Storage
Long Term: -80°C or below,Short Term: -80°C or below

Our Accreditations

Cookie Consent

Cookies help us deliver our services. By using our services, you agree to our use of cookies.